A group of University of Washington undergraduates studying electrical and computer engineering (ECE) have created a low-cost intravenous fluid flow monitoring device that can be used in low- and middle-income nations. Dr. Gregory Valentine of the UW School of Medicine's Department of Paediatrics served as the team's leader.
Leading innovator in drug delivery technology, Baxter International Inc., today released the findings of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH) study conducted with the Starling Fluid Management Monitoring System, which was just published in CHEST. Using a non-invasive dynamic assessment to guide intravenous (IV) fluid and vasopressor administration reduces net fluid balance, mechanical ventilation, and kidney injury in patients with septic shock, according to the results of the FRESH study, which was conducted at 13 hospitals in the United States and the United Kingdom.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5528
Published Date: Jan 11, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are growing use of sustainable material for IV fluid monitoring devices, rising geriatric population, and surge in importance for telemedicine in monitoring.
The market size of IV fluid monitoring devices is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.
The major players in the market are Baxter International, Inc., Pfizer Inc., ICU Medical Inc., Unilife Corporation, and others.
The hospitals & clinics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.